In this sense, it has been reported that variants in the 3′UTR region of the KRAS gene could modify the miRNA-binding sites that could regulate it [19,44,45], and that some of these variants have also been associated with different types of neoplasms [46,47,48,49,50,51]. This evidence concerns the gene KRAS and neoplasm.